As of May 31, 2025, Rocket Pharmaceuticals Inc (RCKT) reports a Gross Margin of 7775.20%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Comparing Rocket Pharmaceuticals Inc's Gross Margin to Peers
To better understand Rocket Pharmaceuticals Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Rocket Pharmaceuticals Inc (RCKT) | 7775.20% |
| W World Corp (WWHC) | 7775.20% |
| TetraLogic Pharmaceuticals Corp (TLOG) | 7775.20% |
| Arno Therapeutics Inc (ARNI) | 7775.20% |
| Atreca Inc (BCEL) | 7775.20% |
| Oncovista Innovative Therapies Inc (OVIT) | 7775.20% |
Compared to its competitors, Rocket Pharmaceuticals Inc's Gross Margin is higher than all peers, indicating superior product pricing power or cost efficiency in production.